•  
  •  
  •  
  •  

2025-10-01 23:39:27

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  ThirumalaiChemicals

Stock Report

  • Update by TCL Specialties LLC, USA
  • Thirumalai Chemicals Ltd posts consolidated loss of Rs. 14.06 crores in Q4 FY25
  • Thirumalai Chemicals Ltd Q1 FY2024-25 consolidated PAT at Rs. 5.09 crores
  • Thirumalai Chemicals Ltd recommends dividend of Rs. 1
  • Thirumalai Chemicals Ltd posts Rs. 20.47 crores consolidated loss in Q4 FY2024
  • TCL Intermediates Pvt Ltd commences commercial production for Greenfield plant at Dahej
  • Thirumalai Chemicals Ltd resumes operations of Phthalic Anhydride plant
  • Thirumalai Chemicals Ltd Q2 FY24 consolidated loss at Rs. 6 crore
  • Thirumalai Chemicals Ltd posts Rs. 10.65 crores consolidated PAT in Q1FY24
  • Thirumalai Chemicals Ltd recommends dividend of Rs. 1.50
  • Thirumalai Chemicals Ltd reports consolidated loss of Rs. 12.84 crores in Q4 FY23
  • Thirumalai Chemicals Ltd consolidated Q3FY23 profit slumps to Rs. 8.30 crores
  • Thirumalai Chemicals Ltd posts consolidated PAT of Rs. 34.32 crores in Q2FY23
  • Thirumalai Chemicals Ltd consolidated net profit for Q1FY23 lower at Rs. 60.05 crores
  • Thirumalai Chemicals Ltd recommends dividend of Rs. 2.50
  • Thirumalai Chemicals Ltd Q4 consolidated profit up at Rs. 90.06 crores in FY22
  • Thirumalai Chemicals reports Rs. 75.46 crores consolidated PAT in Q3 FY22
  • Thirumalai Chemicals Ltd posts Q2FY22 consolidated PAT of Rs. 50.60 crore

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024